chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea 10 mins after vaccine . Rash noted across face and chest indicating allergic reaction. Pt transported to HCF
Skin rash and swelling. Sulfamethoxazole-Trimethoprim 200-40 mg/5ml 8 mgs BID x 10 days.
could not get out of bed; she felt like passed out; having episodic of blood pressure really; dizziness; Pneumonia; nausea; had a temperature; sick for five days; vomited for 3 days; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PNEUMONIA (Pneumonia) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE for Thyroid disorder, PRAMIPEXOLE for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (Pneumonia) (seriousness criterion medically significant), VACCINATION COMPLICATION (sick for five days), MOBILITY DECREASED (could not get out of bed), PRESYNCOPE (she felt like passed out), HYPERTENSION (having episodic of blood pressure really), DIZZINESS (dizziness), VOMITING (vomited for 3 days), NAUSEA (nausea) and PYREXIA (had a temperature). At the time of the report, PNEUMONIA (Pneumonia), MOBILITY DECREASED (could not get out of bed), PRESYNCOPE (she felt like passed out), HYPERTENSION (having episodic of blood pressure really), DIZZINESS (dizziness), NAUSEA (nausea) and PYREXIA (had a temperature) outcome was unknown and VACCINATION COMPLICATION (sick for five days) and VOMITING (vomited for 3 days) had resolved.      It was reported that the blood pressure intervals were high mainly during the day time.  The patient stated that prior to getting the vaccine, she was healthy and was baby sitting for 10 hours. The patient said she had to do stop doing that because she felt like she may drop her grandson since she felt like passed out.  Treatment information was not reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-023313 (Patient Link).
Extreme fatigue everyday since day 2  Fever on day 3 and 4 Heart palpitations
pt given wrong dose of covid series, pt received 10mg but should've received 25mg of moderna vaccine. No reactions noted, pt monitored for 15 minutes.
Sensation of Globus that lasted 10 minutes; This spontaneous case was reported by a physician and describes the occurrence of SENSATION OF FOREIGN BODY (Sensation of Globus that lasted 10 minutes) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced SENSATION OF FOREIGN BODY (Sensation of Globus that lasted 10 minutes). At the time of the report, SENSATION OF FOREIGN BODY (Sensation of Globus that lasted 10 minutes) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.
severe dehydration; extreme exhaustion and extreme fatigue; high heart palpitations; high blood pressure; cold sensation all over the body; I had trouble standing for long periods of time; My skin became so dry especially on the face.; hair became very dry and brittle.; hair became very dry and brittle.; trouble sleeping because of these symptoms; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EN6206) via an unspecified route of administration, administered in right arm on 10Mar2021 at 08:30 (at 37 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included shrimp allergy from unspecified date. There were no concomitant medications. The patient was not diagnosed with COVID-19 prior to vaccination. On 15Mar2021 at 08:00, the patient experienced severe dehydration, extreme exhaustion and extreme fatigue, high heart palpitations, high blood pressure (was never diagnosed before the vaccination), cold sensation all over the body, trouble sleeping because of these symptoms, trouble standing for long periods of time, skin became so dry especially on the face, and hair became very dry and brittle. The events resulted in physician office visit. The events were considered non-serious. Course of events was reported as follows:  the patient experienced severe dehydration, extreme exhaustion and extreme fatigue. She had high heart palpitations, high blood pressure (was never diagnosed with before the vaccination), cold sensation all over the body. The patient had trouble sleeping because of these symptoms and feared that wouldn't wake up because the palpitations were so high and rapid. The patient had trouble standing for long periods of time. Her skin became so dry especially on the face. Her hair became very dry and brittle. She had to take a few weeks off work due to the symptoms stated above. Treatment received included calcium chloride/glucose/magnesium chloride/potassium chloride/sodium chloride/sodium lactate (PEDIALYTE) for dehydration. Since the vaccination, the patient was tested for COVID-19 which included nasal swab on 18Mar2021 and 14Mar2021 which were negative. Outcome of the events was recovered on unspecified date in 2021.
CHEST BEGAN TO HURT, INJECTION POINT BEGAN TO RAISE IN SWELLING AND INTENSE PAIN THAT SHOT DOWN AND UP FROM INJECTION POINT.  DIZZY, NAUSEA. AROUND 18:00 WRIST AND FINGERS OF ARM INJECTED ACHED INTENSELY.  BY 21:00 PAIN AND IMMOBILITY SO INTENSE COULD BARELY RAISE ARM.
Received 2nd anthrax vaccine on 6/508 and within 3-4 hours reacted with diffuse urticarial lesion. Pt did not seek medical evaluation at the time, but treated with BENADRYL and the hives resolved within 24 hours. He denies any rhinorrhea, tightness of chest or throat, itchy throat, facial swelling, dyspnea or cough. Denies GI symptoms. In addition to receiving his 2nd anthrax vaccine on 6/5/08, he had previously received his 2nd Smallpox vaccine on 5/29/08 and denies headaches, body aches, chest pain, fever or fatigue. He reports normal progression of smallpox vaccine site without streaking or swollen axillary lymph nodes. Prior to onset of hives, he denies eating anything out of the ordinary, insect bites, or irritation of new medications. No previous history of hives. Pt stated he is doing fine. Symptoms: Hives.
Body temperature 102°F; Temperature ranging between 99.8°F and 99.2 °F; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of BODY TEMPERATURE INCREASED (Body temperature 102°F) and BODY TEMPERATURE INCREASED (Temperature ranging between 99.8°F and 99.2 °F) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BODY TEMPERATURE INCREASED (Body temperature 102°F) and BODY TEMPERATURE INCREASED (Temperature ranging between 99.8°F and 99.2 °F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BODY TEMPERATURE INCREASED (Body temperature 102°F) and BODY TEMPERATURE INCREASED (Temperature ranging between 99.8°F and 99.2 °F) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature increased: 102*F, 99.8*F, 99.2*F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
LETHARGY, GENERALIZED ACHINESS, FEVER -11/04 0100AM, DYSPHAGIA, FEVER, VERTIGO
I have terrible ringing in my ears.  It began about 8 hours after receiving the first dose and then increased in loudness after the second vaccine dose.  The ringing is noticeably louder than I talk.  I continues to this day.
Developed severe skin rash throughout body.  Went to Emergency Room and was diagnosed as Petechiae.
Shingles;  did not have ocular involvement on ophtho exam but was in correct distribution for this
he noticed his hair has started falling out; This is a spontaneous report from a contactable consumer (patient). A male patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration, on 15Apr2021 as a single dose for COVID-19 immunization. The patient medical history and concomitant medication were not reported. The patient previously took historical vaccine, first dose of BNT162B2 for Covid-19 immunization. Since receiving the vaccine, that was on 15 Apr2021, he noticed his hair has started falling out. The outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Since yesterday, March 17, 2021, after receiving the covid 19 vaccine (Janssen and Johnson vaccine) my left arm was sore from the shot. Last night I developed a severe headache. I felt feverish. All bones seem to be aching. I can hardly move like my normal movement without aches. I felt dizzy and felt tired.
Patient had vaccine and was in the waiting area. He passed out (vasovagal syncope) . We called 911 and he became alert.  He said he felt fine.  The ambulatory team arrive and he passed out again. The took him in the ambulance and monitored him.
Information has been received from a physician concerning a patient who was vaccinated with a dose of varicella virus vaccine live.  On approximately 06/15/2004, the patient presented to the physician with breakthrough chickenpox.  A product quality complaint was not involved.  The reporter also mentioned a second patient who developed chickenpox post vaccination with varicella virus vaccine live.  Additional information has been requested.
Sweaty; Itchy all over; Headache; This spontaneous case was reported by a physician and describes the occurrence of HYPERHIDROSIS (Sweaty), PRURITUS (Itchy all over) and HEADACHE (Headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included SIMVASTATIN, METFORMIN, LINAGLIPTIN (TRAJENTA), LOSARTAN, HYDROCHLOROTHIAZIDE, METOPROLOL, LEVOTHYROXINE SODIUM (SYNTHROID) and OMEPRAZOLE for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced HYPERHIDROSIS (Sweaty), PRURITUS (Itchy all over) and HEADACHE (Headache). On 27-Feb-2021, HYPERHIDROSIS (Sweaty), PRURITUS (Itchy all over) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.
This spontaneous report as received from a registered nurse, refers to an unknown number of patients of unknown age and gender. Patient's pertinent medical history, drug reactions/allergies were not provided. On an unknown date, the nurse reported that vaccines of ROTATEQ (Lot # and expiry date were not provided); vaccines of Tetanus (therapy unspecified) and Diphtheria, were exposed to temperature excursion and were administered to unknown number of patients. The vaccines were exposed to 50F for 1 hour and 5 minutes, and were administered to unspecified number of patients since the temperature excursion. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
No adverse effects at this time; VARIVAX and MMR II were administered at the same time to the patient (first and second doses); This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's relevant medical history, drug reactions/allergies and concomitant medication were not reported.  On 25-FEB-2019, the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck)(VARIVAX) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) for prophylaxis (strength, route, dosage schedule, lot number and expiration date were not reported).      On 11-APR-2019, the patient received the second dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot number R030609, expiration date: 23-OCT-2020; and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (rHa) lot number R015165, expiration date: 29-MAY-2020.      The reporter informed that the second doses were administered in close proximity to the previous first one, but no adverse effects were reported at the time of the report.
Fever to 102.2, severe aching, fatigue.  took Tylenol ES every 4 hours for 24 hours. only Aching the next day, for the most part, only fatigue  for next day or so.  Did not seek medical attention.
Rash and swelling.  Begins one week after shot.  Worse second shot. On arm, rib cage, flank, back, neck and face  Had to use hydrocortisone, Benadryl, Zyrtec, and medrol pak
9-13-08 noon Pts left arm red, swollen, itchy/warm on and off.  Saw Family Physician 9-15-2008, Physician said its a local reaction and a good thing and to do nothing (per patient.)
Pt was given the Booster dose rather than their first dose by pharmacy tech.  Per the CDC recommendation in Appendix A:  "Lower-than-authorized dose volume administered of the correct formulation (e.g., leaked out, equipment failure, recipient pulled away) Repeat dose immediately (no minimum interval).§ However, if a half-volume formulation of vaccine is administered on the same clinic day to a patient recommended for the full volume formulation, another half-volume dose can be administered, and the two doses can count as one full dose." The pt received another half dose.
pt recvd vax & post vax exp t100-102.5 lasting 8 days, & rash (3 different types);pt was treated w/unspecified antibiotics for fever;the fever resolved;the rash periodically returns;
pt recvd vax;pt whined; T 102 at 4pm;rt lateral thigh hot, red,screamed non stop over 2 hrs; to er;seen by MD;
p/receiving flu shot, SOB & palpitations occurred w/in 15mins;pt recvd DecadronIM & pred
At 11:06 AM, patient reports feeling "faint." Patient denies shortness of breath. No rash present; patient denies itching, burning, or pain. At 11:40, patient was sitting up, eating and drinking without complication. Patient released to parent at 11:46 AM. Patient ambulated with steady gait noted.
pt recv vax 6JUN95 & pt exp a fever of 102, vomiting & 40 lesions on the trunk & upper arms approx 10 months p/vax;no further details were provided;
I did not have an adverse reaction to the vaccine.  I started feeling symptoms on 09/29/2022 after being exposed to COVID-19. I had a scratchy throat, sneezing and congestion. On 10/04/2022, I tested positive for COVID-19 via home test.  I went to a walk-in clinic and had a PCR test to confirm. I contacted my primary care physician and was prescribed Paxlovid.
Low grade temp 100.2 Body aches Chills Headache Metallic taste in mouth Pain and bruising in Right arm
Information has been received from a pharmacist concerning a 62 year old hospitalized female with pneumonia, urinary tract infection, diabetes, hypertension, coronary artery disease, dehydration and protein-C deficiency as well as no drug allergies who on 18-MAY-2009 was admitted to the hospitalization for pneumonia, urinary tract infection and dehydration. It was reported that on 19-MAY-2009 she was vaccinated intramuscularly with a 0.5 ml dose of PNEUMOVAX 23 (662687/0983X). Concomitant therapy included LEVAQUIN and vancomycin. She developed redness, pain, and skin blistering at the injection site on left deltoid region around 20-MAY-2009. Recurrent temperatures of 101 Fahrenheit had been recorded for this patient. The patient sought medical attention and was at the hospital. The patient was recently put on vancomycin for cellulitis prophylaxis and was recently given SOLUMEDROL. The patient had recovered. The reporter considered the adverse experiences to be other important medical events. Additional information has been requested.
Slightly swollen , red area at vaccination site, was warm to touch, but no longer; persistant red spot
Storage unit did not record temperature of vaccine. Could not verify for a period of time, vaccine may have been ineffecive; No treatment or adverse reaction.
Myoclonic jerks to left arm and had evaluation for seizures.  Nurse follow up on 10/30/04 states: "benign myoclonus."
pt recvd vax & arm became sore; pt slept most of day & top part of arm was swollen & hard, red, hot to touch, sore;
Developed swelling at injection site, "hard knot" one day post vaccination. Symptoms did not resolve with use of ice packs and NSAIDS.  Referred to ED day 9 days post vaccination. Was treated with steroids; symptoms resolved.
weakness in the legs, hard time walking, arms was very fatigue, hardly walk at all, use cane walker and wheelchair
rash; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 71-year-old female patient received pf-06928316 (ABRYSVO), on 02Sep2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 71 years for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious) with onset 02Sep2023, outcome "unknown". Additional information included: She received Abrysvo last Saturday and suddenly started experiencing a rash. It was the first time that she ever had a vaccine reaction. She would like to report a possible reaction to the RSV vaccine, Abrysvo. She mentioned she was wondering what sort of components are in it besides the antigen itself or any preservatives or carriers that she should know about so that she will know what to do about future vaccines. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt came in complaining of a warm and red arm. I told her to put a cold compress on it and report to a dr if it gets worse.
No adverse effects reported; 3 Patient were administered improperly stored; This spontaneous report as received from a registered nurse, concerning to a 4 month old patient of unknown gender. The patient's historical conditions, concurrent condition, and drug reactions/ allergies were not reported.  On 20-MAY-2019, the patient was vaccinated with improperly stored of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (strength, anatomical location or route of administration were not provided); the nurse was unsure which lots had been administered if lot number R021650 with expiration date 27-MAY-2020 or lot number R021216 with expiration date 25-APR-2020. On the same date, the patient was also vaccinated with improperly stored of hib conj vaccine (ompc)(PEDVAXHIB) (strength, anatomical location or route of administration were not provided); the nurse was unsure which lots had been administered if lot number R021085 and expiration date  07-JUN-2021 or lot number R027321 and expiration date 09-JUL-2021. Both vaccines were administrated as prophylaxis. No adverse effects reported.          The storage temperature of the vaccine was reported as total time and highest temperature above 9 degrees Celsius (°C) (9.3 C, multiple excursions) for 1 hour and 45 minutes. There were no previous temperature excursions. The digital data logger was involved.  This is one of several reports received from the same reporter.  Lot number and expiration date were reported in the source document. But, when entering the lot number in MARRS the system automatically auto-populated the correct expiration date, which sometimes  may differs from the expiration date reported by the source.; Sender's Comments:  US-009507513-1906USA000495: US-009507513-1906USA000496: US-009507513-1906USA000497:
21 year old healthy female G2P1001, one prior full term healthy vaginal delivery, presented to initial obstetric visit on 01/10/2019 at 12weeks1day gestation. Last menstrual period of 10/17/2018 provided an estimated due date of 07/24/2019. Ultrasound evaluation during physical exam revealed a single intrauterine pregnancy measuring 11weeks6days, consistent with dating by her period, confirming a due date of 07/24/2019. Patient was counseled by me (the physician) on risks and benefits of the flu vaccine. Patient received the flu vaccine by the nurse practitioner, as routine in the office. Patient's routine blood work returned all normal the following week. Patient returned for a routine scheduled follow up prenatal visit on 02/14/2019, at 17weeks1d. On exam, by my partner, she was diagnosed with a fetal demise, which measured 13weeks5days. She is being scheduled to have a dilation and curettage for early next week.
Information has been received from a physician who was told by a patient's mother that a female patient with a sulfa allergy who on an unspecified date was vaccinated with a first dose of GARDASIL (lot number, injection site and route not reported), which was well tolerated. On an unspecified date, the patient was vaccinated with a second dose of GARDASIL (lot number, injection site and route not reported). Subsequently the patient died. The cause of death was reported as allergic reaction to GARDASIL. The physician stated that the patient who died was not her patient and she knew no further details. Follow-up information was received from the physician who reported that a other of one of her patients had said to her, that she "thought" she read this report on the internet. The physician asked the patient's mother to find out where she read the report. The patient's mother could not find the report and did not know where to locate the source information. Additional information has been requested.
my wife died of a hart attack 4 days after her shot she was only 30 years old,. with no previous symtoms. please explain to me how this could happen.
Fever 102.6 for three days - total weakness for 8 eight day. Unable to get out of bed - eating. No appetite - to weak could no prepare food.
"  Patient is a 73 YO female with h/o COPD, lung cancer s/p treatment, DM2, CKD3, HTN, HLD, admitted with acute COPD exacerbation due to COVID. She was treated with usual care including prednisone, duonebs and pulmonary hygiene. Was give remdesivir as well for COVID-19 infection. Symptoms improved slowly over the course of several days. She was weaned off oxygen and returned to near baseline. Discharged home in good condition."